Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe so-called golden dose of Mounjaro refers to the point in your titration schedule where weight loss feels most effective relative to side effects — often cited as 7.5mg or 10mg, though the right stopping point is different for every person. It is not a clinical term, and no prescriber can tell you in advance which dose will be yours. Mounjaro (tirzepatide) is a prescription-only medicine; the dose you take is decided by a GPhC-registered prescriber after reviewing your response, tolerability and overall health — not by a community shorthand.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The phrase travelled from online patient communities, where people noticed that a particular dose seemed to hit a sweet spot: meaningful weight loss, manageable nausea, good energy. That experience is real. What varies enormously is which dose delivers it. For one person it is 7.5mg; for another it is 10mg or 12.5mg; a small number find 5mg is all they need. No algorithm predicts it, and the NHS tirzepatide medicines page does not use the term at all.
What the clinical evidence does show is that higher doses produce greater average weight loss. In SURMOUNT-1, participants on 15mg lost around 20–21% of body weight on average over 72 weeks, a figure cited in NICE's appraisal of tirzepatide (TA1026). Lower doses produced less weight loss on average, but still clinically meaningful amounts. So the question is not simply "which dose works" but "which dose works for you, at a level you can sustain."
Tolerability matters as much as efficacy. Gastrointestinal side effects (nausea, loose stools, reflux) are most noticeable early in treatment or after a dose increase. Many people find they settle within a week or two. If they do not, holding the current dose for longer rather than pressing upward is a legitimate and often sensible choice. Your body's response is data your prescriber needs.
Deciding whether to stay at your current dose or move up involves weighing several things. Weight-loss progress is one: if you are losing steadily, your prescriber may reasonably suggest holding. Side-effect burden is another: persistent nausea or fatigue that is affecting daily life signals that your system has not yet settled, and increasing the dose before it does usually makes things worse, not better.
There is also the question of whether you have genuinely plateaued. A slowdown in week six of a dose can simply be the body recalibrating, a true plateau usually means several weeks with no movement despite consistent habits. That distinction matters when deciding whether to go up a dose. If you are weighing it up right now, the question of whether to increase your dose is worth reading through before your next review.
Lifestyle factors sit underneath all of this. Mounjaro works alongside a reduced-calorie diet and increased activity, the licence is explicit on that point. If diet quality or activity has slipped, a dose increase will not fully compensate. That is not a judgment; it is a practical observation that prescribers often share.
The cost picture is also real. Mounjaro prices vary by dose and provider. If you are curious about how the numbers stack up, the context around Mounjaro pricing in the UK covers what influences the cost at different strengths. A dose you can afford to sustain long-term is clinically relevant too.
Titrating to 15mg is not the goal for everyone. The licensed schedule gives prescribers flexibility precisely because different people reach a satisfactory outcome at different points. If you are losing weight at a rate your prescriber considers clinically appropriate, tolerating the pen well, and managing your routine without disruption (the pen stored in the fridge alongside everyday items, taken on the same day each week) there is no clinical imperative to keep pushing higher.
Some people worry that staying at, say, 7.5mg or 10mg means leaving results on the table. That may or may not be true for you individually; it depends on whether your current dose is still active or whether loss has genuinely stalled. The 7.5mg dose page covers what the evidence says about outcomes at that strength specifically, which may help frame the conversation with your prescriber.
The concept of a golden dose is useful as a conversation-starter, not a destination. Bring it up at your next review: what is my current weight-loss trajectory, is my side-effect profile telling me anything, and is there a clinical reason to move up or a reason to hold? Those are the right questions, and if you want a structured way to think them through, our guide to what dose of Mounjaro you should take is a good place to start before speaking to your prescriber.
At nume, every repeat order is clinically re-reviewed before it is dispensed. A GPhC-registered prescriber reads your updated answers (weight, side effects, any new medicines or health changes) rather than simply reissuing the last prescription. That means if you are at 5mg and wondering about whether 5mg is still working for you, or if you are at 10mg and unsure whether to go to 12.5mg, those questions get considered by a clinician who knows your notes, not processed automatically.
If you are not yet on treatment and want to understand the full Mounjaro treatment overview before deciding, or if you want a broader look at weight-loss treatment options generally, both are worth reading first. When you are ready to have this conversation with a prescriber, start your free consultation and a clinician will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.